A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Srinivasan, S.
- Budget Blues and Brownie Points
Authors
Source
The Indian Practitioner, Vol 70, No 2 (2017), Pagination: 7-7Abstract
It is that time of the year when all eyes and ears are turned towards the Finance Ministry and the Parliament House as they unleash a slew of measures that will determine the fate of the nation in the coming 52 weeks. And true to tradition, the budget comes out as the proverbial Curate's egg that is good but only in parts. This year's budget too is no exception.- Quo Vadis Medical Ethics?
Authors
Source
The Indian Practitioner, Vol 70, No 3 (2017), Pagination: 7-7Abstract
Just a few weeks ago, the tranquil waters of hospital medicine suddenly turned murky and turbulent, thanks to the unpardonable levels of moral depravity exhibited by some medical and paramedical staff in some leading medical institutions including the seemingly noble white coat wearers with serene faces. The problem arose with the capricious availability and arbitrary pricing of that life-saving tube called stent, which has now become the epicenter of the earthquake that is shaking the entire medical world.- An Unwelcome Guest who overstays Forever
Authors
Source
The Indian Practitioner, Vol 70, No 4 (2017), Pagination: 7-8Abstract
Let's face it. Amongst all diseases, tuberculosis never was, is or will have the glamour quotient of say coronary artery disease or lifestyle disorders of the affluent in order to find a place in cocktail circuit chattering mouthed by the elite perched on ivory towers in five star hotels.- Iron Deficiency Anemia:Newer Perspectives
Authors
Source
The Indian Practitioner, Vol 70, No 4 (2017), Pagination: 22-28Abstract
Iron deficiency anemia is one of the most prevalent nutritional deficiencies, worldwide. The objective of this article is to inform practitioners on salient features of this condition. This review article covers the causes of iron deficiency, the diagnosis and the various treatment options available.
Anemia is a result from surgical and medical conditions. The first line of therapy for patients with iron deficiency anemia (IDA) is oral iron supplementation. Patients in whom gastrointestinal blood loss exceeds the intestinal ability to absorb iron may develop iron refractory iron deficiency anemia (IRIDA). Laboratory diagnosis showed serum ferritin is an extremely powerful test for diagnosis of iron deficiency anemia. Tests confirmed that Red cell distribution width (RDW) are not affected in anemia in chronic inflammation.
Alternative to oral iron route is intravenous treatment. Intravenous iron is more effective than oral iron when combined with ESA in chronic kidney disease. Intravenous iron supplementation fell out of favor secondary to the presence of infrequent but serious side effects. When planning to administer a large iron dose in single dose in single infusion the risk benefits ratio should be evaluated.
- Oh No, Not Again!
Authors
Source
The Indian Practitioner, Vol 70, No 5 (2017), Pagination: 7-8Abstract
Senior stakeholders in healthcare with a strong background cum expertise may be experiencing a deja vu of sorts with the recent rekindling of the generic versus brand debate that keeps making headlines every now and then, only to vanish or go into hibernation once public interest wanes and newer and 'hotter' news items arrive to push them out.- Infectious Diarrhoeas–A Perspective
Authors
Source
The Indian Practitioner, Vol 70, No 6 (2017), Pagination: 36-42Abstract
Gastrointestinal problems are very common and endemic in India and other developing countries. From an ordinary stomach upset to various types of diarrhoeas, the causes for infections could range from intake of unhygienically prepared food, contaminated water, also person to person contact and even other reasons. A host of bacteria and viruses could be responsible.
This article compiled by our Executive Editor, Dr S Srinivasan comprehensively covers and reviews the entire spectrum of diarrhoeas, its epidemiology, clinical presentations and treatment options.
- There's more to Monsoon than Garam Chai and Pakodas
Authors
Source
The Indian Practitioner, Vol 70, No 7 (2017), Pagination: 7-8Abstract
Monsoon is the time when the romantic, poetic, adventuristic, naturalistic and other lofty spirits of human beings come to the fore in full swing. The alluring visuals the TV channels and travel magazines dish out with unending stretches of greenery and cascading waters would make you go gaga at first sight and head to the nearest hill station or tourist spot to soak it all in. But alas, monsoon time is also a time for illnesses galore, some of which can be serious and even life threatening.- The Inflammation-Pain-Fatigue Triad
Authors
Source
The Indian Practitioner, Vol 70, No 7 (2017), Pagination: 27-33Abstract
Two common symptoms which are present in acute or chronic high-grade inflammatory diseases such as infection, rheumatoid diseases or cancers are fatigue and pain. These symptons are often associated with depression. Several markers of inflammation have been highlighted in all such diseases and among various and complex mechanisms of action, one common link between fatigue and pain is inflammation. Some inflammatory cytokines are found to be associated with all these three domains - ie fatigue, depression and pain. Thus inflammation is a potential link for all three.
This review article explores in detail the triad of inflammation-pain-fatigue in the context of various medical conditions.
- Pumped up Phobias on Proton Pump Inhibitors ?
Authors
Source
The Indian Practitioner, Vol 70, No 8 (2017), Pagination: 7-8Abstract
Over the years, proton pump inhibitor (PPI) use has skyrocketed worldwide and India is no exception. These agents are very effective in treating gastroesophageal reflux disease (GERD), healing peptic ulcers, and preventing gastrointestinal bleeding in patients on non steroidal anti-inflammatory therapy (NSAIDs), aspirin (ASA), and blood thinners. Over the years, these agents have been "implicated" in causing several side effects. In some instances there are clear "associations", but rarely have there been true established "cause and effect".- GERD Fast becoming a Lifestyle Disorder
Authors
1 The Indian Practitioner, IN
Source
The Indian Practitioner, Vol 70, No 8 (2017), Pagination: 21-26Abstract
Acidity and hyperacidity have become endemic and widespread, virtually symbolic of urbanised living and a fast life. Reflux of gastric components into the oesphagus takes place and today gastroesophageal reflux diseases (GERD) is characterised as a lifestyle disorder. Causes are many, primarily due to improper dietary habits, high stress factors in a fast paced life including inadequate sleep and rest. While neutralising the acid using a range of alkaline substances is what is normally resorted to, it does not address the underlying causes. This article provides an overview of this disorder, the other complications including cancer that can arise from uncontrolled GERD, the range of foods that lead to this and how it could be addressed.- The Menace of Osteoporosis
Authors
Source
The Indian Practitioner, Vol 70, No 9 (2017), Pagination: 7-10Abstract
It won't be an exaggeration to say that osteoporosis is almost universal in Indian elderly women and is also a serious threat to quality of life in all senior citizens regardless of sex. Increasing longevity has resulted in an increasing number of senior citizens globally; life expectancy at present is 67 years in India and is expected to increase to 71 years by 2025 and to 77 years by 2050.- A Review of the Aetiology, Characterisation, Diagnosis and Treatment of Alzheimer's Disease
Authors
Source
The Indian Practitioner, Vol 70, No 9 (2017), Pagination: 26-45Abstract
Not too long ago, Alzheimer's (AD) disease was looked upon as a problem affecting only rich countries and affluent societies and therefore not of much relevance to a country like India. Not so any more. In India, 3.7 million people are said to be affected by this condition as of 2016 with the figure doubling by the year 2030. Compare this with the figures for the United States where AD affects 5.4 million people as of 2017 with the number rising to 13.8 million by the year 2050. Clearly we in India cannot afford to be complacent on this front, especially because more and more senior citizens are now living up to ripe old age putting enormous pressure on our limited healthcare resources.References
- Alzheimer disease. Shaheen E Lakhan, Medscape Jul 26, 2017
- Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016 Apr. 12 (4):459-509.
- Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015 Dec. 86 (12):1299-306
- Anderson, P. Early-Life Depression Boosts Alzheimer’s Risk. Medscape Medical News. July 24, 2017
- Chiang GC, Insel PS, Tosun D, et al. Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology. 2010 Nov 30. 75(22):1976-81
- Rodrigue KM, Rieck JR, Kennedy KM, Devous MD, Diaz-Arrastia R, Park DC. Risk Factors for ßAmyloid Deposition in Healthy Aging: Vascular and Genetic Effects. JAMA Neurol. 2013 Mar 18. 1-7.
- Schrijvers JCM, Witteman EJG, Sijbrands, et al. Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology. 2010;75:19821987.
- Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology. 2010 Jul 6. 75(1):35-41
- Lowry F. Late-life depression linked to increased risk for dementia. Medscape Medical News. May 7, 2013
- Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of communitybased cohort studies. Br J Psychiatry. 2013 May. 202:329-35
- Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med. 2009 May 28. 360(22):23029
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011 May. 7(3):263-9. .
- American Psychiatric Association. Neurocognitive Disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013. 611-614.
- McMillan CT, Avants B, Irwin DJ, Toledo JB, et al. Can MRI screen for CSF biomarkers in neurodegenerative disease?. Neurology. 2012 Dec 26
- Brooks M. Functional Brain Imaging May Spot Alzheimer’s Early. Medscape Medical News. Aug 21 2013
- Greig SL. Memantine ER/Donepezil: A Review in Alzheimer’s Disease. CNS Drugs. 2015 Nov. 29 (11):963-70
- Small GW. Treating dementia and agitation. JAMA. 2014 Feb 19. 311(7):677-8
- Wang YY, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang YT. Meta-analysis of randomized, doubleblind, placebo-controlled trials of melatonin in Alzheimer’s disease. Int J Geriatr Psychiatry. 2016 Sep 19.
- Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014 Jan 1. 311(1):33-44.
- Yaffe K, Boustani M. Benzodiazepines and risk of Alzheimer’s disease. BMJ. 2014 Sep 9. 349:g5312.